Clinical Trials
11 trialsNCT02526511 2026-06-02
Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors
Rutgers, The State University of New Jersey
Phase NA Completed
NCT05410509 2026-06-02
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
University of Alabama at Birmingham
Phase NA Completed
NCT02231749 2026-05-27
Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)
Bristol-Myers Squibb
Phase 3 Completed
NCT03260894 2026-05-22
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Incyte Corporation
Phase 3 Completed
NCT04687969 2026-05-22
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
Completed
NCT04846920 2026-05-22
MK-6482-018
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT00898365 2026-05-18
Study of Kidney Tumors in Younger Patients
Children's Oncology Group
Completed
NCT01334073 2026-05-14
EVAX
University Hospital, Bordeaux
Phase 1 Completed
NCT01624220 2026-05-12
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
M.D. Anderson Cancer Center
Phase NA Completed
NCT04987203 2026-05-08
Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc.
Phase 3 Completed
NCT06056505 2026-05-05
3DPN
University of Leipzig
Phase NA Completed